The minicircle (MC), composed of eukaryotic sequences only, is an interesting approach to increase the safety and efficiency of plasmid-based vectors for gene therapy. In this paper, we investigate micro-MC (miMC) vectors encoding small regulatory RNA. We use a construct encoding a splice-correcting U7 small nuclear RNA, which results in a vector of 650 base pairs (bp), as compared to a conventional 3600 bp plasmid carrying the same expression cassette. Furthermore, we construct miMCs of varying sizes carrying different number of these cassettes. This allows us to evaluate how size influences production, super-coiling, stability and efficiency of the vector. We characterize coiling morphology by atomic force microscopy and measure the resis...
Es gibt unterschiedliche Verfahren zur Manipulation und Modifikation von Zellen zur Expression von r...
A barrier limiting the use of nonviral vectors for gene therapy is related to the short duration of ...
Plasmid DNA (pDNA) vectors are the current conventional technology driving therapeutic gene transfer...
In gene therapy, the aim is to change the behaviour of a cell by introduction of genetic material, o...
Minicircle DNA vectors consisting of a circular expression cassette devoid of the bacterial plasmid ...
Targeted genetic modification using programmable nucleases such as zinc finger nucleases (ZFNs) and ...
We have previously described the development of a scaffold/matrix attachment region (S/MAR) episomal...
Plasmid DNA is frequently used particularly for nonviral gene therapy. Conventional plasmid DNA cont...
Minicircle DNA is a promising tool in the field of gene therapy, whose products are increasingly gai...
An ideal vector for gene therapy must fulfil the following requirements: non-toxicity, mitotic stabi...
Double-stranded DNA minicircles of less than 1000 bp in length have great interest in both fundament...
The ability to produce extremely small and circular supercoiled vectors has opened new territory for...
The breakthrough of genetic therapy is set back by the lack of suitable genetic vector systems. We p...
Minicircle (MC) DNA vectors are able to generate a high-level transgene expression in vivo, which is...
DNA vectors for human gene therapy have to meet the efficacy and safety requirements. Minicircles (M...
Es gibt unterschiedliche Verfahren zur Manipulation und Modifikation von Zellen zur Expression von r...
A barrier limiting the use of nonviral vectors for gene therapy is related to the short duration of ...
Plasmid DNA (pDNA) vectors are the current conventional technology driving therapeutic gene transfer...
In gene therapy, the aim is to change the behaviour of a cell by introduction of genetic material, o...
Minicircle DNA vectors consisting of a circular expression cassette devoid of the bacterial plasmid ...
Targeted genetic modification using programmable nucleases such as zinc finger nucleases (ZFNs) and ...
We have previously described the development of a scaffold/matrix attachment region (S/MAR) episomal...
Plasmid DNA is frequently used particularly for nonviral gene therapy. Conventional plasmid DNA cont...
Minicircle DNA is a promising tool in the field of gene therapy, whose products are increasingly gai...
An ideal vector for gene therapy must fulfil the following requirements: non-toxicity, mitotic stabi...
Double-stranded DNA minicircles of less than 1000 bp in length have great interest in both fundament...
The ability to produce extremely small and circular supercoiled vectors has opened new territory for...
The breakthrough of genetic therapy is set back by the lack of suitable genetic vector systems. We p...
Minicircle (MC) DNA vectors are able to generate a high-level transgene expression in vivo, which is...
DNA vectors for human gene therapy have to meet the efficacy and safety requirements. Minicircles (M...
Es gibt unterschiedliche Verfahren zur Manipulation und Modifikation von Zellen zur Expression von r...
A barrier limiting the use of nonviral vectors for gene therapy is related to the short duration of ...
Plasmid DNA (pDNA) vectors are the current conventional technology driving therapeutic gene transfer...